Phathom Pharmaceuticals
PHAT
PHAT
118 hedge funds and large institutions have $551M invested in Phathom Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9.7% less ownership
Funds ownership: 91.94% → 82.24% (-9.7%)
14% less funds holding
Funds holding: 137 → 118 (-19)
50% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 36
Holders
118
Holding in Top 10
6
Calls
$15.4M
Puts
$12.1M
Top Buyers
| 1 | +$22.6M | |
| 2 | +$16.6M | |
| 3 | +$6.45M | |
| 4 |
6CM
683 Capital Management
New York
|
+$6.33M |
| 5 |
MCM
Moore Capital Management
New York
|
+$5.75M |
Top Sellers
| 1 | -$44.2M | |
| 2 | -$9.36M | |
| 3 | -$7.52M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.41M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.83M |
